GSK
Latest statistics and disclosures from GSK's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001131399
Tip: Access up to 7 years of quarterly data
Positions held by GSK consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for GSK
GSK holds 13 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Crispr Therapeutics Namen Akt (CRSP) | 29.2 | $176M | 3.2M | 54.54 |
|
|
| Wave Life Sciences SHS (WVE) | 17.6 | $106M | 18M | 5.81 |
|
|
| Vir Biotechnology (VIR) | 14.5 | $87M | 8.6M | 10.19 |
|
|
| Biontech Se Sponsored Ads (BNTX) | 13.7 | $83M | 890k | 93.05 |
|
|
| Ideaya Biosciences (IDYA) | 8.3 | $50M | 1.3M | 37.27 |
|
|
| Cytokinetics Com New (CYTK) | 4.8 | $29M | 340k | 85.19 |
|
|
| Lyell Immunopharma Com New (LYEL) | 3.5 | $21M | 1.5M | 14.05 |
|
|
| Spero Therapeutics (SPRO) | 3.4 | $20M | 9.2M | 2.21 |
|
|
| Nkarta (NKTX) | 1.5 | $8.9M | 3.2M | 2.83 |
|
|
| Fulcrum Therapeutics (FULC) | 1.1 | $6.5M | 1.8M | 3.66 |
|
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.1 | $6.5M | 1.5M | 4.24 |
|
|
| CVRX (CVRX) | 0.9 | $5.2M | 1.0M | 5.14 |
|
|
| Regenxbio Inc equity us cm (RGNX) | 0.5 | $3.3M | 272k | 11.98 |
|
Past Filings by GSK
SEC 13F filings are viewable for GSK going back to 2026
- GSK 2026 Q2 filed Aug. 13, 2026